208 related articles for article (PubMed ID: 5964006)
41. [Data for the study of reactogenic and epidemiological effectiveness of a live measles vaccine prepared from the Leningrad-16 strain].
Nikitin MIa; Kozlova NA; Kulikova VA; Petrova TN
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():321-9. PubMed ID: 5860951
[No Abstract] [Full Text] [Related]
42. [Vaccination against measles].
Cocchi P; Corti R
Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
[TBL] [Abstract][Full Text] [Related]
43. [Relationship between the age of the child and the degree of body temperature and antibody titre after vaccination against measles].
Domorázková E; Janotová J; Vodicková M; Drevo M
Cesk Pediatr; 1975 Oct; 30(10):468-70. PubMed ID: 1212713
[No Abstract] [Full Text] [Related]
44. The role of herd immunity in control of measles.
Black FL
Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
[TBL] [Abstract][Full Text] [Related]
45. Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine.
Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
Kitasato Arch Exp Med; 1974 Jun; 47(1-2):13-21. PubMed ID: 4476032
[No Abstract] [Full Text] [Related]
46. [Anti-measles vaccination with inactivated virus].
Terragna A; Roscioli B; De Marco B
G Mal Infett Parassit; 1967 Apr; 19(4):219-22. PubMed ID: 5614197
[No Abstract] [Full Text] [Related]
47. [Vaccination against measles].
Ek E
Tidsskr Nor Laegeforen; 1971 Jan; 91(2):135-7. PubMed ID: 5539605
[No Abstract] [Full Text] [Related]
48. Mass measles vaccination: experience with live attenuated virus vaccine in and around Vellore.
Benjamin V; Jadhav M; Roberts PO
Indian Pediatr; 1969 Mar; 6(3):102-13. PubMed ID: 5784931
[No Abstract] [Full Text] [Related]
49. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
[TBL] [Abstract][Full Text] [Related]
50. Seroconversion after measles vaccination in infants and children.
Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
[No Abstract] [Full Text] [Related]
51. [Single or double dose of vaccine needed for the eradication of measles in Spain?].
Vitoria Miñana I; Morales Suárez-Varela M; Cotanda Gutiérrez P; Asensi Botet F
An Esp Pediatr; 1993 Feb; 38(2):130-4. PubMed ID: 8439098
[TBL] [Abstract][Full Text] [Related]
52. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
Dilraj A; Sukhoo R; Cutts FT; Bennett JV
Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
[TBL] [Abstract][Full Text] [Related]
53. [Measles today].
Feo F; Angela GC
Minerva Med; 1966 Mar; 57(22):954-73. PubMed ID: 5948625
[No Abstract] [Full Text] [Related]
54. [Results of the inoculation test of measles vaccine. 3. The result of Schwarz vaccine (highly attenuated live virus vaccine)].
Santo K
Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):356-60. PubMed ID: 6070598
[No Abstract] [Full Text] [Related]
55. Measles antibody response in vaccinated children.
Evliyaoğlu N; Altintaş D; Kiliç NB; Alhan SE; Onenli N; Güneşer S; Bahçebaşi T
Turk J Pediatr; 1996; 38(3):315-21. PubMed ID: 8827900
[TBL] [Abstract][Full Text] [Related]
56. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
Ikić DM
Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
[TBL] [Abstract][Full Text] [Related]
57. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
58. [Postvaccinal measles immunity characteristics of Leningrad children].
Smorodinova IP; Zubov AK; Sobolevskaia AA; Kaplan AS; Smordintsev AA
Tr Inst Im Pastera; 1979; 53():66-70. PubMed ID: 162464
[No Abstract] [Full Text] [Related]
59. [Experiences with the live measles vaccine].
Vivell O; Lips G
Arch Kinderheilkd; 1967; 176(2):156-63. PubMed ID: 5592896
[No Abstract] [Full Text] [Related]
60. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
Chiarini A; Brancato P; Sinatra A
Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
